{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:50:04Z","timestamp":1794030604167,"version":"4.8.0"},"reference-count":188,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.tins.2022.12.004","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:45:33Z","timestamp":1673603133000},"page":"176-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["The foundation and architecture of precision medicine in neurology and psychiatry"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-8982","authenticated-orcid":false,"given":"Harald","family":"Hampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-0173","authenticated-orcid":false,"given":"Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-6384","authenticated-orcid":false,"given":"Andrea","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2022.12.004_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-020-2817-4","article-title":"Strategic vision for improving human health at the forefront of genomics","volume":"586","author":"Green","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tins.2022.12.004_bb0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41380-019-0463-8","article-title":"A polygenic resilience score moderates the genetic risk for schizophrenia","volume":"26","author":"Hess","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrd4793","article-title":"Two decades of new drug development for central nervous system disorders","volume":"14","author":"Kesselheim","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tins.2022.12.004_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41582-021-00529-1","article-title":"The human connectome in Alzheimer disease - relationship to biomarkers and genetics","volume":"17","author":"Yu","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0035","first-page":"459","article-title":"Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd.2017.226","article-title":"Drug development in the era of precision medicine","volume":"17","author":"Dugger","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tins.2022.12.004_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease","volume":"76","author":"Karran","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105225","article-title":"Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration","volume":"149","author":"Noori","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2022.12.004_bb0055","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1038\/s41598-020-71813-1","article-title":"The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2022.12.004_bb0060","doi-asserted-by":"crossref","first-page":"61rv66","DOI":"10.1126\/scitranslmed.3000446","article-title":"Lost in translation: neuropsychiatric drug development","volume":"2","author":"Becker","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0065","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.tins.2022.12.004_bb0070","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nn.3806","article-title":"Neural compensation in older people with brain amyloid-beta deposition","volume":"17","author":"Elman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41582-022-00642-9","article-title":"Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes","volume":"18","author":"Gomez-Isla","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","article-title":"Glymphatic failure as a final common pathway to dementia","volume":"370","author":"Nedergaard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0090","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41380-020-00915-z","article-title":"Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap","volume":"26","author":"Schwarz","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41398-020-0705-1","article-title":"ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across more than 40 countries","volume":"10","author":"Thompson","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101662","article-title":"Time for the systems-level integration of aging: resilience enhancing strategies to prevent Alzheimer's disease","volume":"181","author":"Hampel","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tins.2022.12.004_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrclinonc.2010.227","article-title":"Predictive, personalized, preventive, participatory (P4) cancer medicine","volume":"8","author":"Hood","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tins.2022.12.004_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41582-020-0409-4","article-title":"Impact of predictive, preventive and precision medicine strategies in epilepsy","volume":"16","author":"Nabbout","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0115","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S1470-2045(15)00620-8","article-title":"Precision oncology: origins, optimism, and potential","volume":"17","author":"Prasad","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tins.2022.12.004_bb0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1535370217740861","article-title":"The FDA Oncology Center of Excellence and precision medicine","volume":"243","author":"Goldberg","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tins.2022.12.004_bb0125","first-page":"6","article-title":"Precision medicine becomes reality-tumor type-agnostic therapy","volume":"38","author":"Yan","year":"2018","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.tins.2022.12.004_bb0130","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104976","article-title":"Genetic architecture of Alzheimer's disease","volume":"143","author":"Neuner","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2022.12.004_bb0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-genom-082410-101459","article-title":"Genetics of schizophrenia: new findings and challenges","volume":"12","author":"Gejman","year":"2011","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrg.2017.4","article-title":"Autism genetics: opportunities and challenges for clinical translation","volume":"18","author":"Vorstman","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-019-0581-5","article-title":"A framework for the investigation of rare genetic disorders in neuropsychiatry","volume":"25","author":"Sanders","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0165","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1126\/science.aaa8954","article-title":"Genetics and genomics of psychiatric disease","volume":"349","author":"Geschwind","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tins.2022.12.004_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0180","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0185","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0190","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41593-018-0240-z","article-title":"Deconstructing and targeting the genomic architecture of human neurodegeneration","volume":"21","author":"De Jager","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuron.2013.10.046","article-title":"Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology","volume":"80","author":"McCarroll","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2022.12.004_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tig.2019.02.005","article-title":"Progress in polygenic composite scores in Alzheimer's and other complex diseases","volume":"35","author":"Chasioti","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41398-019-0612-5","article-title":"Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders","volume":"9","author":"Jonas","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2019.06.006","article-title":"Polygenic risk scores for developmental disorders, neuromotor functioning during infancy, and autistic traits in childhood","volume":"87","author":"Serdarevic","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41398-019-0485-7","article-title":"Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment","volume":"9","author":"Chaudhury","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0225","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/s41467-021-24082-z","article-title":"Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores","volume":"12","author":"Leonenko","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0230","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.euroneuro.2017.06.005","article-title":"A polygenic risk score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans","volume":"27","author":"Rampino","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.tins.2022.12.004_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.b.32581","article-title":"A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains","volume":"177","author":"Ranlund","year":"2018","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0240","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0245","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2012.02.009","article-title":"Personal omics profiling reveals dynamic molecular and medical phenotypes","volume":"148","author":"Chen","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tins.2022.12.004_bb0250","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41591-019-0414-6","article-title":"A longitudinal big data approach for precision health","volume":"25","author":"Schussler-Fiorenza Rose","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0255","doi-asserted-by":"crossref","first-page":"eaau8650","DOI":"10.1126\/science.aau8650","article-title":"The NASA Twins Study: a multidimensional analysis of a year-long human spaceflight","volume":"364","author":"Garrett-Bakelman","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-016-1612-7","article-title":"The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism","volume":"132","author":"Klein","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2022.12.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101346","article-title":"Omics sciences for systems biology in Alzheimer's disease: state-of-the-art of the evidence","volume":"69","author":"Hampel","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tins.2022.12.004_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ejn.13760","article-title":"A review of genome-wide transcriptomics studies in Parkinson's disease","volume":"47","author":"Borrageiro","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2020.06.005","article-title":"Transcriptomic insight into the polygenic mechanisms underlying psychiatric disorders","volume":"89","author":"Hernandez","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0280","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0285","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","article-title":"Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease","volume":"7","author":"Ping","year":"2020","journal-title":"Sci. Data"},{"key":"10.1016\/j.tins.2022.12.004_bb0290","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41398-021-01664-5","article-title":"The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors","volume":"11","author":"Notaras","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0295","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fpsyt.2019.00647","article-title":"Untargeted metabolomics for autism spectrum disorders: current status and future directions","volume":"10","author":"Glinton","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2022.12.004_bb0310","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","article-title":"Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review","volume":"135","author":"Andersen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.tins.2022.12.004_bb0320","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2022.12.004_bb0325","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fphar.2019.00310","article-title":"Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: cornerstones for Alzheimer's precision medicine and pharmacology","volume":"10","author":"Hampel","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tins.2022.12.004_bb0330","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0335","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0340","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0345","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13195-021-00918-0","article-title":"In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease","volume":"13","author":"Levin","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2022.12.004_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0355","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.28375","article-title":"Brain microglial activation increased in glucocerebrosidase (GBA) mutation carriers without Parkinson's disease","volume":"36","author":"Mullin","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113004","article-title":"Molecular imaging of schizophrenia: neurochemical findings in a heterogeneous and evolving disorder","volume":"398","author":"Cumming","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2022.12.004_bb0365","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2022.12.004_bb0370","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0375","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hbm.23434","article-title":"Age prediction on the basis of brain anatomical measures","volume":"38","author":"Valizadeh","year":"2017","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.tins.2022.12.004_bb0380","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/s41598-018-23696-6","article-title":"Identification of individual subjects on the basis of their brain anatomical features","volume":"8","author":"Valizadeh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2022.12.004_bb0385","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/s41467-020-15631-z","article-title":"Dynamic reconfiguration of functional brain networks during working memory training","volume":"11","author":"Finc","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0390","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0395","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/mp.2015.109","article-title":"Brain connectomics predict response to treatment in social anxiety disorder","volume":"21","author":"Whitfield-Gabrieli","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0400","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1038\/ncomms11254","article-title":"A small number of abnormal brain connections predicts adult autism spectrum disorder","volume":"7","author":"Yahata","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/brain.2019.0693","article-title":"Atypical relationships between spontaneous EEG and fMRI activity in autism","volume":"10","author":"Mash","year":"2020","journal-title":"Brain Connect"},{"key":"10.1016\/j.tins.2022.12.004_bb0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41537-020-00113-4","article-title":"A multimodal magnetoencephalography 7 T fMRI and 7 T proton MR spectroscopy study in first episode psychosis","volume":"6","author":"Gawne","year":"2020","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.tins.2022.12.004_bb0415","first-page":"3889","article-title":"Combination of FMRI-SMRI-EEG data improves discrimination of schizophrenia patients by ensemble feature selection","volume":"2014","author":"Sui","year":"2014","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.tins.2022.12.004_bb0420","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nicl.2016.08.009","article-title":"Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia","volume":"12","author":"Ford","year":"2016","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.tins.2022.12.004_bb0425","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1002\/hbm.24238","article-title":"Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity","volume":"39","author":"Smit","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.tins.2022.12.004_bb0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barabasi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41568-020-0240-7","article-title":"A census of pathway maps in cancer systems biology","volume":"20","author":"Kuenzi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tins.2022.12.004_bb0440","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-021-21146-y","article-title":"Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes","volume":"12","author":"Maron","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0445","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrn2575","article-title":"Complex brain networks: graph theoretical analysis of structural and functional systems","volume":"10","author":"Bullmore","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0450","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1104635","article-title":"Systems biology and new technologies enable predictive and preventative medicine","volume":"306","author":"Hood","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0455","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41380-018-0304-1","article-title":"Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain","volume":"25","author":"Radulescu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13195-017-0252-z","article-title":"Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach","volume":"9","author":"Hu","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2022.12.004_bb0465","doi-asserted-by":"crossref","first-page":"W423","DOI":"10.1093\/nar\/gkn282","article-title":"KEGG Atlas mapping for global analysis of metabolic pathways","volume":"36","author":"Okuda","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tins.2022.12.004_bb0470","first-page":"1370","article-title":"Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data","volume":"19","author":"Yan","year":"2018","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.tins.2022.12.004_bb0475","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2020.11.002","article-title":"Transformative network modeling of multi-omics data reveals detailed circuits, key regulators, and potential therapeutics for Alzheimer's disease","volume":"109","author":"Wang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2022.12.004_bb0480","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41593-019-0382-7","article-title":"A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data","volume":"22","author":"Wang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0485","doi-asserted-by":"crossref","first-page":"eaat8464","DOI":"10.1126\/science.aat8464","article-title":"Comprehensive functional genomic resource and integrative model for the human brain","volume":"362","author":"Wang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0490","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3233\/JAD-179932","article-title":"Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology","volume":"64","author":"Hampel","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2022.12.004_bb0495","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.25406","article-title":"Longitudinal tau accumulation and atrophy in aging and alzheimer disease","volume":"85","author":"Harrison","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116991","article-title":"Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults","volume":"220","author":"Scott","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.tins.2022.12.004_bb0505","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/brain\/awr066","article-title":"Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden","volume":"134","author":"Drzezga","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.tins.2022.12.004_bb0510","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/alz.12249","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults","volume":"17","author":"Harrison","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2022.12.004_bb0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fnagi.2017.00319","article-title":"Early changes in alpha band power and DMN BOLD activity in Alzheimer's disease: a simultaneous resting state EEG-fMRI study","volume":"9","author":"Brueggen","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0520","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-019-14159-1","article-title":"Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease","volume":"11","author":"Franzmeier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2022.12.004_bb0525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnagi.2020.00125","article-title":"Brain functional and structural signatures in Parkinson's disease","volume":"12","author":"Liu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0530","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/brain\/awaa035","article-title":"Impaired theta phase coupling underlies frontotemporal dysconnectivity in schizophrenia","volume":"143","author":"Adams","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tins.2022.12.004_bb0535","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jocn.2019.03.054","article-title":"Incremental benefits of EEG informed fMRI in the study of disorders related to meso-corticolimbic dopamine pathway dysfunction: a systematic review of recent literature","volume":"65","author":"Syed Nasser","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0540","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.tins.2022.12.004_bb0545","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nicl.2018.05.021","article-title":"Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia","volume":"19","author":"Chung","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.tins.2022.12.004_bb0550","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/brain.2020.0785","article-title":"Regional disconnection in Alzheimer dementia and amyloid-positive mild cognitive impairment: association between EEG functional connectivity and brain glucose metabolism","volume":"10","author":"Smailovic","year":"2020","journal-title":"Brain Connect"},{"key":"10.1016\/j.tins.2022.12.004_bb0555","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2967\/jnumed.120.248500","article-title":"Dopaminergic nigrostriatal connectivity in early Parkinson disease: in vivo neuroimaging study of (11)C-DTBZ PET combined with correlational tractography","volume":"62","author":"Sanchez-Catasus","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0560","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2020.01.012","article-title":"Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD study","volume":"90","author":"Babiloni","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2022.12.004_bb0565","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2016.08.021","article-title":"Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study","volume":"48","author":"Babiloni","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2022.12.004_bb0570","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","article-title":"Mapping neurotransmitter systems to the structural and functional organization of the human neocortex","volume":"25","author":"Hansen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0575","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamapsychiatry.2020.2694","article-title":"Virtual histology of cortical thickness and shared neurobiology in 6 psychiatric disorders","volume":"78","author":"Writing Committee for the Attention-Deficit\/Hyperactivity Disorder","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0580","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.tins.2022.12.004_bb0585","doi-asserted-by":"crossref","first-page":"eabc6457","DOI":"10.1126\/sciadv.abc6457","article-title":"Network-based atrophy modeling in the common epilepsies: a worldwide ENIGMA study","volume":"6","author":"Lariviere","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2022.12.004_bb0590","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41746-019-0084-2","article-title":"Digital biomarkers for Alzheimer's disease: the mobile\/ wearable devices opportunity","volume":"2","author":"Kourtis","year":"2019","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0595","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/mds.27376","article-title":"Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial","volume":"33","author":"Lipsmeier","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0600","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.parkreldis.2017.07.022","article-title":"Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases","volume":"46","author":"Artusi","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0605","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/mds.27671","article-title":"A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies","volume":"34","author":"Espay","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0610","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.parkreldis.2021.01.006","article-title":"The use of wearable\/portable digital sensors in Huntington's disease: a systematic review","volume":"83","author":"Tortelli","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2022.12.004_bb0615","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jamaneurol.2018.0809","article-title":"Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score","volume":"75","author":"Zhan","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0620","doi-asserted-by":"crossref","first-page":"eabd7865","DOI":"10.1126\/scitranslmed.abd7865","article-title":"Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson's disease","volume":"13","author":"Powers","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0625","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.9775","article-title":"Predicting mood disturbance severity with mobile phone keystroke metadata: a BiAffect digital phenotyping study","volume":"20","author":"Zulueta","year":"2018","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.tins.2022.12.004_bb0630","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamapsychiatry.2017.3838","article-title":"A solution-focused research approach to achieve an implementable revolution in digital mental health","volume":"75","author":"Mohr","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0635","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2174\/1567205016666191010124011","article-title":"Actigraphy for assessing light effects on sleep and circadian activity rhythm in Alzheimer's dementia: a narrative review","volume":"16","author":"Canazei","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tins.2022.12.004_bb0640","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(17)31218-7","article-title":"Digitising the mind","volume":"389","author":"Barrett","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tins.2022.12.004_bb0645","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/wps.20472","article-title":"The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials","volume":"16","author":"Firth","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0650","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0655","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.aaa8415","article-title":"Machine learning: trends, perspectives, and prospects","volume":"349","author":"Jordan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tins.2022.12.004_bb0660","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40537-022-00650-y","article-title":"A practical Alzheimer disease classifier via brain imaging-based deep learning on 85,721 samples","volume":"9","author":"Lu","year":"2022","journal-title":"J. Big Data"},{"key":"10.1016\/j.tins.2022.12.004_bb0665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/acm2.13121","article-title":"A review on medical imaging synthesis using deep learning and its clinical applications","volume":"22","author":"Wang","year":"2021","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.tins.2022.12.004_bb0670","series-title":"2018 IEEE 15th International Symposium on Biomedical Imaging","article-title":"Brain MRI super resolution using 3D deep densely connected neural networks","author":"Chen","year":"2018"},{"key":"10.1016\/j.tins.2022.12.004_bb0675","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41593-019-0520-2","article-title":"A deep learning framework for neuroscience","volume":"22","author":"Richards","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0680","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.schres.2017.10.023","article-title":"Improving individual predictions: machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases)","volume":"214","author":"Schnack","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tins.2022.12.004_bb0685","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroimage.2017.03.057","article-title":"A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages","volume":"155","author":"Rathore","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.tins.2022.12.004_bb0690","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnagi.2019.00220","article-title":"Deep learning in Alzheimer's disease: diagnostic classification and prognostic prediction using neuroimaging data","volume":"11","author":"Jo","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0695","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer's disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0700","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2019.08.032","article-title":"Biomarker-guided clustering of Alzheimer's disease clinical syndromes","volume":"83","author":"Toschi","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2022.12.004_bb0705","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fnagi.2018.00390","article-title":"Uncovering biologically coherent peripheral signatures of health and risk for Alzheimer's disease in the aging brain","volume":"10","author":"Riedel","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0710","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2215-0366(15)00471-X","article-title":"Cross-trial prediction of treatment outcome in depression: a machine learning approach","volume":"3","author":"Chekroud","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0715","article-title":"A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study","volume":"6","author":"Hampel","year":"2020","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.tins.2022.12.004_bb0720","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2589-7500(20)30200-4","article-title":"Time to reality check the promises of machine learning-powered precision medicine","volume":"2","author":"Wilkinson","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.tins.2022.12.004_bb0725","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jgs.16218","article-title":"Passive digital signature for early identification of Alzheimer's disease and related dementia","volume":"68","author":"Boustani","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.tins.2022.12.004_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2019.101771","article-title":"Predicting dementia with routine care EMR data","volume":"102","author":"Ben Miled","year":"2020","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0735","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","article-title":"Drug discovery with explainable artificial intelligence","volume":"2","author":"Jimenez-Luna","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.tins.2022.12.004_bb0740","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42256-019-0088-2","article-title":"The global landscape of AI ethics guidelines","volume":"1","author":"Jobin","year":"2019","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.tins.2022.12.004_bb0745","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.tins.2022.12.004_bb0750","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.neuron.2022.09.012","article-title":"Challenges for machine learning in clinical translation of big data imaging studies","volume":"110","author":"Dinsdale","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2022.12.004_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101555","article-title":"Toward noninvasive brain stimulation 2.0 in Alzheimer's disease","volume":"75","author":"Menardi","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tins.2022.12.004_bb0760","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2022.12.004_bb0765","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0770","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2022.12.004_bb0775","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","article-title":"A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer's disease","volume":"4","author":"Seyfried","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.tins.2022.12.004_bb0780","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0785","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","article-title":"A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2022.12.004_bb0790","doi-asserted-by":"crossref","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","article-title":"A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease","volume":"14","author":"Zhao","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0795","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41593-021-00948-9","article-title":"A data-driven framework for mapping domains of human neurobiology","volume":"24","author":"Beam","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0800","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14283\/jpad.2020.22","article-title":"Early detection of mild cognitive impairment (MCI) in an at-home setting","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.tins.2022.12.004_bb0805","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.dadm.2014.11.012","article-title":"Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease","volume":"1","author":"Konig","year":"2015","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.tins.2022.12.004_bb0810","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1038\/s41598-019-49275-x","article-title":"Novel method for rapid assessment of cognitive impairment using high-performance eye-tracking technology","volume":"9","author":"Oyama","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2022.12.004_bb0815","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JGP.0b013e31823038af","article-title":"Decreased daytime motor activity associated with apathy in Alzheimer disease: an actigraphic study","volume":"20","author":"David","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.tins.2022.12.004_bb0820","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1570159X19666211201095701","article-title":"Biological mechanism-based neurology and psychiatry: a BACE1\/2 and downstream pathway model","volume":"21","author":"Hampel","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.tins.2022.12.004_bb0825","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-pharmtox-010611-134520","article-title":"Systems pharmacology: network analysis to identify multiscale mechanisms of drug action","volume":"52","author":"Zhao","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tins.2022.12.004_bb0830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/psp4.12478","article-title":"Quantitative systems pharmacology for neuroscience drug discovery and development: current status, opportunities, and challenges","volume":"9","author":"Geerts","year":"2020","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.tins.2022.12.004_bb0835","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/d41586-019-01366-5","article-title":"Account for sex in brain research for precision medicine","volume":"569","author":"Ferretti","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tins.2022.12.004_bb0840","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","article-title":"Sex differences in movement disorders","volume":"16","author":"Meoni","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0845","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41386-019-0408-6","article-title":"Developmentally divergent sexual dimorphism in the cortico-striatal-thalamic-cortical psychosis risk pathway","volume":"44","author":"Jacobs","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2022.12.004_bb0850","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain Abeta load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2022.12.004_bb0855","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","article-title":"Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau","volume":"75","author":"Hohman","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0860","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jalz.2018.05.014","article-title":"Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints","volume":"14","author":"Cavedo","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2022.12.004_bb0865","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41582-018-0115-7","article-title":"Nature and implications of sex differences in AD pathology","volume":"15","author":"Babapour Mofrad","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2022.12.004_bb0870","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnagi.2015.00130","article-title":"Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease","volume":"7","author":"Christensen","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2022.12.004_bb0875","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yfrne.2018.06.001","article-title":"Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification","volume":"50","author":"Hampel","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.tins.2022.12.004_bb0880","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-018-1122-7","article-title":"From hype to reality: data science enabling personalized medicine","volume":"16","author":"Frohlich","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0885","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.stem.2018.05.019","article-title":"Toward precision medicine for neurological and neuropsychiatric disorders","volume":"23","author":"Gibbs","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2022.12.004_bb0890","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2021.01.015","article-title":"Precision medicine in 2030-seven ways to transform healthcare","volume":"184","author":"Denny","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tins.2022.12.004_bb0895","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \"a white paper, community perspective\"","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.tins.2022.12.004_bb0900","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"GTEx Consortium","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0905","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature23018","article-title":"Large-scale physical activity data reveal worldwide activity inequality","volume":"547","author":"Althoff","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2022.12.004_bb0910","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \"All of Us\" research program","volume":"381","author":"All of Us Research Program Investigators","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0920","first-page":"184","article-title":"Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening","volume":"69","author":"Smith","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tins.2022.12.004_bb0925","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tins.2022.12.004_bb0930","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nbt.4017","article-title":"Precision oncology in the age of integrative genomics","volume":"36","author":"Kumar-Sinha","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tins.2022.12.004_bb0935","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41591-019-0725-7","article-title":"Big data is crucial to the early detection of cancer","volume":"26","author":"Fitzgerald","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2022.12.004_bb0940","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223622002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223622002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:22:04Z","timestamp":1759062124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223622002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":188,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0166223622002582"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2022.12.004","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The foundation and architecture of precision medicine in neurology and psychiatry","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}